Rossouw, J. E., G. L. Anderson, R. L. Prentice, A. Z. LaCroix, C. Kooperberg, M. L. Stefanick, R. D. Jackson, S. A. Beresford, B. V. Howard, K. C. Johnson, J. M. Kotchen, and J. Ockene. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women’s health initiative randomized controlled trial. Journal of the American Medical Association 288(3):321–333.
Safran, C., M. Bloomrosen, W.E. Hammond, S. Labkoff, S. Markel-Fox, P. C. Tang, D. E. Detmer, with input from the expert panel. 2007. Toward a national framework for the secondary use of health data: An american medical informatics association white paper. Journal of the American Medical Informatics Association 14(1):1-9. http://www.healthlawyers.org/Members/PracticeGroups/HIT/Toolkits/Documents/5_Health_Data_AMIA_Summary.pdf (accessed August 18, 2008).
Snader, C. E., T. H. Marwick, F. J. Pashkow, S. A. Harvey, J. D. Thomas, and M. S. Lauer. 1997. Importance of estimated functional capacity as a predictor of all-cause mortality among patients referred for exercise thallium single-photon emission computed tomography: Report of 3,400 patients from a single center. Journal of the American College of Cardiology 30(3):641–648.
Stukel, T. A., E. S. Fisher, D. E. Wennberg, D. A. Alter, D. J. Gottlieb, and M. J. Vermeulen. 2007. Analysis of observational studies in the presence of treatment selection bias: Effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. Journal of the American Medical Association 297(3):278–285.
Topol, E. J., and R. M. Califf. 1994. Scorecard cardiovascular medicine. Its impact and future directions. Annals of Internal Medicine 120(1):65–70.
Turner, E. H., A. M. Matthews, E. Linardatos, R. A. Tell, and R. Rosenthal. 2008. Selective publication of antidepressant trials and its influence on apparent efficacy. New England Journal of Medicine 358(3):252–260.